Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose intravenous microdose pharmacokinetic study of three investigational HIV integrase inhibitors in healthy men
NL-OMON42414Active, not recruiting
- Sponsor
- Merck & Co.
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of L-810,191 in Human immunodeficiency virus infection type 1 (3 arms), sponsored by Merck & Co. Primary endpoint: Preliminary plasma pharmacokinetics. Started Apr 2015; status: active, not recruiting.
02
Drugs
L-810,191
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on NL-OMON42414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42414.